Plant Cell Fermentation (PCF®) Technology
Innovator of sustainable solutions to overcome supply constraints for active compounds derived from rare, hard to source, slow-growing or endangered species.
Award-winning, environmentally responsible biotechnology for development of phytochemicals at commercial scale across various industries
Proprietary library of hundreds of plant cell cultures of vascular and non-vascular plants accessible for your development project
Strictly controlled GMP-compliant supply and production processes enable tight product consistency and quality in accordance with regulatory standards
A sustainable solution able to overcome supply constraints for actives derived from rare, hard-to-source, slow-growing or endangered plant species
Scalable, cost-competitive industrial production from kgs to tonnes of annual product volumes
Phyton Biotech offers clients a full range of integrated contract product and process development and commercial manufacturing services across the entire development chain, from feasibility to commercial production.
Latest News
Latest News
Phyton Biotech Announces the Successful Establishment of Plant Cell Lines to Source Key Building Block for Treatment of Rare Dermatologic Conditions
Phyton Biotech’s Plant Cell Fermentation (PCF) technology has been successfully used to develop high-yielding plant cell lines of the source of cyclopamine, a key raw material for PellePharm’s patedigib topical gel.
Latest Events
Latest Case Study
Case Study: Using Green Chemistry to Produce Taxol
Taxol® (manufactured by Bristol-Myers Squibb) is an important drug used to treat many types of solid tumor cancers and Kaposi’s sarcoma. It is on the World Health Organization’s List of Essential Medicines, the most needed medicines in a health care system.